New products and markets propel company’s growth
Two lab product companies go public with mixed results
R&D, sales and capex annual totals for pharma & biotech, chemicals, and industrial metals & mining companies
Two companies each make 8 acquisitions
As digitization continues to transform the R&D landscape, new funding mechanisms are required
Chan Zuckerberg, Harvard Medical School and NIH announcements
NSF establishes mid-scale opportunities to address discrepancy in research funding
Survey examines labs’ instrument service preferences
A new endorsement for long-read technology
Representatives from global analytical instrument and lab product trade organizations speak to IBO about the future of the industry
Pay Invoice
Latest Blogs
-
SDi Forecasts Growth in Demand for Analytical Instruments 2024–2029
May 29, 2025 1:38 pm
-
NIH Disruptions and Lab Tool Companies: Stocks React
April 30, 2025 1:17 pm
-
Federal R&D Obligations for the NIH Decline in FY24
March 27, 2025 3:02 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
